Stapuldencel-T

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A dendritic cell (DC)-based cancer vaccine composed of autologous dendritic cells (DCs) activated with a prostate tumor cell lysate containing tumor-associated antigens (TAAs) with potential immunostimulatory and antineoplastic activities. Upon administration, stapuldencel-T may stimulate an anti-tumoral cytotoxic T-lymphocyte (CTL) response against prostate cancer cells expressing prostate tumor cell-specific antigens, which may result in prostate tumor cell lysis.

**Synonyms:** - DCVAC/PCa - Prostate Tumor Antigen-activated Autologous Dendritic Cell Vaccine - STAPULDENCEL